2022 Scientific Retreat- Session 11

Session 11: Novel Gamma Delta T Cell Therapy Platforms for Oncology 
29th Annual PCF Scientific Retreat: October 29, 2022 | 10:00 AM – 11:45 AM 

Moderator: Marco Gottardis, PhD 
Janssen Research & Development, LLC 

Introduction 
Marco Gottardis, PhD 
Janssen Research & Development, LLC 

Primer on the Biology of γδ T cells and their Use in Cancer Cell Therapy 
Sandy Hayes, PhD 
Janssen 

Novel γδ T Cell Therapy Platform 
Lawrence Lamb, Jr., PhD 
IN8bio 

Bispecific γδ T Cell Engagers for the Treatment of Prostate Cancer 
Paul Parren, PhD 
LAVA Therapeutics 

Using iPSC-derived γδ CAR-T cells to Overcome the TME barrier in Solid Tumors 
Hy Levitsky, MD 
CENTURY TX